retatrutide prescription Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval Status 2026:

Our products are not for human consumption under any circumstances

Smart Scale Renpho Smart Scale Using a smart scale is incredibly helpful on a GLP-1 journey, as it enables you to track your body composition over time. Products like the Renpho Smart Scale provide data beyond a simple weight measurement, including skeletal muscle mass, body fat percentage, and visceral fat (the fat around your organs)

Retatrutide is a triple agonist acting at GIP, GLP-1, and glucagon receptors, whereas semaglutide targets GLP-1 alone [4][3]

Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes

Due to the limited research on microdosing, the body's long-term response to these reduced doses remains unpredictable

It helps reduce fat accumulation by promoting healthy digestion, reducing inflammation, and balancing blood sugar levels